J&J Fires up the Surgical Robotics Market with New Verb Deal (MDDI)
The New Brunswick, N.J.-based company said it would acquire the remaining stake in Verb Surgical, a joint venture the company has with Verily.
Earlier this year, MD+DI asked if Johnson & Johnson was becoming a surgical robotics powerhouse. This seems to be the case now that the New Brunswick, N.J.-based company has said it will acquire the remaining stake in the Verb Surgical joint venture it has with Verily. The companies did not disclose the financial details of deal, which is expected to close in the first half of 2020.
In a release, J&J’s Worldwide Chairman, Medical Devices Ashley McEvoy said, "We have reached this important milestone thanks to the progress the Verb Surgical team has made with their digital surgery platform and the strong collaboration with Verily, Ethicon, and the clinicians around the world who shared their passion, deep insights, and clinical expertise. We are building a truly differentiated digital surgery ecosystem to change the standard of care for generations to come, and our collaboration with Verily has enabled us to advance our vision to help improve outcomes fo...
